علاج مرض الزهايمر في سويسرا

تشهد سويسرا تطورًا ملحوظًا في توفير الرعاية المتخصصة لمرضى الزهايمر في مستشفياتها الخاصة، حيث يتم التركيز على تقديم برامج علاجية مبتكرة تراعي احتياجات كل مريض بشكل فردي. كما تضم الفرق الطبية أخصائيين ذوي خبرة يسعون لتحسين جودة الحياة للمرضى من خلال تقديم الدعم العلاجي والنفسي المستمر.

Alzheimer's disease. Alzheimer's disease is now the most common form of neurodegenerative dementia in the United States with a disproportionate disease burden in minority populations. Deficits in the ability to encode and store new memories characterizes the initial stages of the disease. Subsequent progressive changes in cognition and behavior accompany the later stages. Changes in amyloid precursor protein (APP) cleavage and production of the APP fragment beta-amyloid (Aβ) along with hyperphosphorylated tau protein aggregation coalesce to cause reduction in synaptic strength, synaptic loss, and neurodegeneration. Metabolic, vascular, and inflammatory changes, as well as comorbid pathologies are key components of the disease process. Symptomatic treatment offers a modest, clinically measurable effect in cognition, but disease-modifying therapies are desperately needed. Copyright © 2019 Elsevier B.V. All rights reserved.